The New York Times profiled Joy Milne, a and the co-author of several papers on the topic.
Cold and heat exposure in infancy appeared to influence in children. (Nature Climate Change)
The Global CEO Initiative on Alzheimer's Disease recommended performance standards for in primary and secondary care. (Nature Reviews Neurology)
World Trade Center responders were at risk for , with toxic dust exposure after the 9/11 attack possibly playing a role. (JAMA Network Open)
Tau PET outperformed MRI and amyloid PET as a for progression from mild cognitive impairment to dementia. (JAMA Neurology)
The first (Emflaza) to treat Duchenne muscular dystrophy (DMD) was approved, Cranbury Pharmaceuticals announced.
Pfizer reported that its fordadistrogene movaparvovec, did not meet its primary endpoint of improvement in motor function in a phase III trial.
Takeda said investigational of seizure reduction in phase III trials of Dravet syndrome and Lennox-Gastaut syndrome.
Angiotensin receptor blockers (ARBs) were linked with a in people with hypertension compared with other antihypertensive drugs. (JAMA Neurology)
Prolonged exposure to elevated depressive symptoms starting in young adulthood led to over 20 years. (Neurology)
A assessed early Parkinson's symptoms. (NPJ Parkinson's)
Brain research has tremendous promise but that demand more than just regulatory compliance, NIH researchers said in a New England Journal of Medicine essay.